Myosin-Related Dilated Cardiomyopathy: Another Elephant Emerges From Darkness
- PMID: 36202535
- PMCID: PMC12053530
- DOI: 10.1016/j.jacc.2022.08.749
Myosin-Related Dilated Cardiomyopathy: Another Elephant Emerges From Darkness
Keywords: MYH7; dilated cardiomyopathy; genetics.
Conflict of interest statement
Funding Support and Author Disclosures Dr Lanfear is supported in part by grants from the National Institutes of Health (P50MD017351, R01HL132154); has received research funding or support from Amgen, AstraZeneca, Eli Lilly, and SomaLogic; and has acted as consultant to ACI Clinical (Abbott Laboratories), AstraZeneca, Cytokinetics, Duke Clinical Research Institute (CONNECT-HF), Illumina, Janssen, Martin Pharmaceuticals, Ortho Clinical Diagnostics, Otsuka, and Vicardia. Dr Reza is a site subinvestigator for the Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants (NCT04572893).
Comment on
-
Natural History of MYH7-Related Dilated Cardiomyopathy.J Am Coll Cardiol. 2022 Oct 11;80(15):1447-1461. doi: 10.1016/j.jacc.2022.07.023. Epub 2022 Aug 22. J Am Coll Cardiol. 2022. PMID: 36007715
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
